Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CBLB for treating endotoxin-mediated disorders

CBLB for treating endotoxin-mediated disorders

US Patent 8168176 · Granted May 1, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

KIF13B-derived peptide and method of inhibiting angiogenesis2022
Peptides for treating cancer2018
Compositions and methods for diagnosing or treating neutrophil-mediated inflamma2018
Peptides for inhibiting angiogenesis2017
Compositions and methods for diagnosing or treating neutrophil-mediated inflamma2017
Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, 2016
Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, 2014
Selected endothelial progenitor cells and methods for use2012
Silencing of TGFβ type II receptor expression by siRNA2011
Modulation of MLCK-L expression and uses thereof2010
Peptide carrier for drug delivery2008
Transcytosis vehicles and enchancers for drug delivery2001